In March 2025, the company declared new designs to get a direct-to-shopper offering of its Wegovy weight loss drug. The company founded a completely new pharmacy, known as NovoCare, which would demand consumers $499 each month for entry to the drug, below half the cost of the drug by means of other pharmaceutical distribution networks.[fifty three]